Advanced search×

Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists

Bioorg Med Chem Lett 20(9):5 (2010) PMID 20382019

A series of 4-(3-biaryl)quinolines with sulfone substituents on the terminal aryl ring (8) was prepared as potential LXR agonists. High affinity LXR@b ligands with generally modest binding selectivity over LXR@a and excellent agonist potency in LXR functional assays were identified. Many compounds had LXR@b binding IC"5"0 values <1.0nM in an ABCA1 mRNA induction assay in J774 mouse cells with efficacy comparable to T0901317. Sulfone 8a was further evaluated in LDL (-/-) mice and shown to reduce atherosclerotic lesion progression.

DOI: 10.1016/j.bmcl.2010.03.031
Version: za2963e q8zaf q8zbf q8zcd q8zdc q8zee q8zff q8zg6

Similar articles you may find interesting…

  1. Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.

    J Med Chem 53(8):3296-304 (2010) PMID 20350005

    These results suggest quinoxaline 13 may have an improved biological profile for potential use as a therapeutic agent....
  2. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally dif...

    J Biol Chem 278(40):38821-8 (2003) PMID 12819202

    The structures of the liver X receptor LXRbeta (NR1H2) have been determined in complexes with two synthetic ligands, T0901317 and GW3965, to 2.1 and 2.4 A, respectively. Together with its isoform LXRalpha (NR1H3) it regulates target genes involved in metabolism and transport of cholesterol and fatty...
  3. Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases.

    IDrugs 12(12):734-737 (2009) PMID 19943211

    The 39th Annual Meeting of the Society for Neuroscience (SFN), held in Chicago, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on novel neuroprotective and antiparkinsonian agents, and compo...